Arcus Biosciences grants new hires options for 18,400 shares at $28.18 each

Arcus Biosciences, Inc.

Arcus Biosciences, Inc.

RCUS

0.00
  • Arcus Biosciences granted two new employees stock options for 18,400 shares, exercise price USD 28.18, based on the June 23 close.
  • Issued restricted stock units covering 9,250 shares under the company’s 2020 Inducement Plan.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcus Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606241635BIZWIRE_USPR_____20260624_BW737996) on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.